…DOI treatment prevented the majority of the asthma-like symptoms wrought by ovalbumin exposure. DOI-treated asthmatic mice could breathe normally, and did not show the expected increase in mucus production and inflammation that one would expect in this model of asthma.
Furthermore, the researchers could ameliorate this type of asthma with a dosage of DOI that was 100 times lower than the dosage required to elicit behavioral symptoms – raising the possibility that low doses of DOI might be able to treat human asthma without causing a psychedelic experience.
There could be a lot more benefit. Serotonin is believed to be involved in migraines. The theory has not been proven to date, but potentially this could treat migraines as well.
That said, it’d be only a matter of time before people stockpile DOI in hopes of getting the psychedelic experience.